BILL ANALYSIS                                                                                                                                                                                                    �



                                                                      



           ------------------------------------------------------------ 
          |SENATE RULES COMMITTEE            |                   ACR 71|
          |Office of Senate Floor Analyses   |                         |
          |1020 N Street, Suite 524          |                         |
          |(916) 651-1520         Fax: (916) |                         |
          |327-4478                          |                         |
           ------------------------------------------------------------ 
           
                                         
                                 THIRD READING


          Bill No:  ACR 71
          Author:   Fletcher (R)
          Amended:  As introduced
          Vote:     21

           
           ASSEMBLY FLOOR  :  78-0, 8/25/11 (Consent) - See last page 
            for vote


           SUBJECT  :    Plasma Protein Therapies Month

           SOURCE  :     Author


           DIGEST  :    This resolution designates September 2011 as 
          Plasma Protein Therapies Month and encourages Californians 
          to observe the month with appropriate programs and 
          activities

           ANALYSIS  :    This resolution makes the following 
          legislative findings: 

          1. Patients with rare, chronic, genetic diseases and 
             disorders rely upon access to plasma-derived and 
             recombinant analog therapies, known collectively as 
             "plasma protein therapies," to treat life-threatening 
             conditions, such as hemophilia and primary 
             immunodeficiency diseases. 

          2. Individuals afflicted with these rare disorders require 
             access to the full range of plasma protein therapies to 
             help ensure the best possible clinical outcomes. 
                                                           CONTINUED





                                                                ACR 71
                                                                Page 
          2


          3. Access to comprehensive care has been shown to markedly 
             improve patient outcomes, including access to options in 
             pharmacy services and the delivery of home supported 
             services. 

          4. There are 10 plasma collection centers in California 
             certified by the International Quality Plasma Program 
             where healthy, committed donors provide plasma used to 
             manufacture high impact, life-saving therapies. 

           FISCAL EFFECT  :    Fiscal Com.:  No


           ASSEMBLY FLOOR  :  78-0, 8/25/11
          AYES:  Achadjian, Alejo, Allen, Ammiano, Atkins, Beall, 
            Bill Berryhill, Block, Blumenfield, Bradford, Brownley, 
            Buchanan, Butler, Charles Calderon, Campos, Carter, 
            Cedillo, Chesbro, Conway, Cook, Davis, Dickinson, 
            Donnelly, Eng, Feuer, Fletcher, Fong, Fuentes, Furutani, 
            Beth Gaines, Galgiani, Garrick, Gatto, Gordon, Grove, 
            Hagman, Halderman, Hall, Harkey, Hayashi, Roger 
            Hern�ndez, Hill, Huber, Hueso, Huffman, Jeffries, Jones, 
            Knight, Lara, Logue, Bonnie Lowenthal, Ma, Mansoor, 
            Mendoza, Miller, Mitchell, Monning, Morrell, Nestande, 
            Nielsen, Norby, Olsen, Pan, Perea, V. Manuel P�rez, 
            Portantino, Silva, Skinner, Smyth, Solorio, Swanson, 
            Torres, Valadao, Wagner, Wieckowski, Williams, Yamada, 
            John A. P�rez
          NO VOTE RECORDED:  Bonilla, Gorell


          CTW:mw  9/6/11   Senate Floor Analyses 

                       SUPPORT/OPPOSITION:  NONE RECEIVED

                                ****  END  ****